GlassScriptPhysician profile
Brad H Norman
NPI 1013998608
$1,056.25
in general payments reported to CMS, 2019-2025
20 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.21 · 2020: $108 · 2021: $30.06 · 2022: $104 · 2023: $222 · 2024: $233 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $636 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.86 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $294.08 | 2023-2025 | Veozah |
| Abbvie INC. | $144.86 | 2020-2023 | |
| Shield Therapeutics INC | $140.48 | 2023-2024 | Accrufer |
| Exeltis, USA INC. | $84.85 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $49.68 | 2022-2025 | Myosure Tissue Removal Device, Novasure |
| Coopersurgical, INC. | $41.08 | 2020-2023 | Summit Doppler |
| Sumitomo Pharma America, INC. | $40.57 | 2023-2024 | Myfembree |
| Pfizer INC. | $39.62 | 2020-2022 | |
| Lupin INC. | $35.64 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.78 | 2021-2024 | |
| Therapeuticsmd, INC. | $23.35 | 2022 | |
| Amag Pharmaceuticals, INC. | $22.97 | 2019 | |
| Organon LLC | $19.98 | 2025 | Nexplanon |
| Meditrina | $17.21 | 2024 | |
| Mission Pharmacal Company | $15.30 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.26 | 2025 | Evenity |
| Aspira Women'S Health INC | $13.18 | 2021 | |
| Allergan, INC. | $12.99 | 2020 | |
| Myovant Sciences INC. | $12.37 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brad Norman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.